
Lonza to Establish Global Contract Manufacturing Operations in Hyderabad
Lonza Group AG Establishes Global Capability Centre in Hyderabad
Lonza Group AG, a leading contract development and manufacturing organisation, has selected Hyderabad as the location for its new Global Capability Centre (GCC). This strategic decision further solidifies Telangana's position as a prominent global life sciences hub.
Background and Decision
Following months of evaluation and discussions with state leadership, Lonza finalised its decision to establish the GCC in Hyderabad. The company met with Telangana's Industries & Commerce Minister D. Sridhar Babu and Telangana Lifesciences CEO Shakthi M. Nagappan to formally communicate its plan.
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
Key Figures and Performance
Lonza, founded in 1897, operates across more than 30 sites worldwide with nearly 20,000 employees. The company reported CHF 6.5 billion in sales and CHF 2.1 billion in Core EBITDA in 2022.
Reasons for Selection
Lonza cited Hyderabad's talent pool, quality infrastructure, and supportive industrial ecosystem as key reasons for its selection.
Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
Impact and Future Prospects
The new GCC is expected to generate high-value employment and deepen Hyderabad's integration into the global biopharma value chain. Telangana already hosts a growing concentration of multinational R&D, manufacturing, and digital capability centres, and Lonza's entry further strengthens its standing among global life sciences destinations.
Global Life Sciences Ecosystem
Lonza's investment is the latest in a series of global bets on Hyderabad's life sciences ecosystem, which has been expanding rapidly across biologics, vaccines, CRDMO services, and global capability hubs. With this move, the company joins a cluster of international players leveraging the city's technology base, scientific workforce, and government support.
Investor Takeaway
Investors should consider the long-term growth potential of the life sciences sector in India.
More in Economy

Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

MoSPI Releases Uniform Norms for DDP Estimates with 2022-23 Base Year
